摩根士丹利维持爱尔康"均配"评级

华尔街洞察
Jul 15

摩根士丹利最新研报维持对爱尔康公司(ALC)的"均配"(Equal-Weight)评级。分析师认为该股当前估值合理,既未呈现显著上行空间,亦无明显下行压力。

市场观察人士指出,此次评级延续了机构对该眼科器械巨头的审慎立场。爱尔康在人工晶体和手术器械领域的全球领先地位虽获认可,但面临新兴市场竞争加剧及产品迭代周期延长的双重挑战。

https://www.benzinga.com/quote/ALC/analyst-ratings

上述评级发布于2025年7月15日09:13(美东时间13:13)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10